46.46.Z - Wholesale of pharmaceutical goods
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
52.10.B - Warehousing and storage of other goods
70.22.Z - Business and other management consultancy activities
71.20.B - Other technical testing and analysis
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,5 | 1 | 1 | 0,7 |
Gross profit (loss) | 0,5 | 1,1 | 1,2 | 9,7 |
EBITDA | 0,7 | 1,2 | 1,1 | -8 |
Short time liabilities | 0,7 | 1 | 1,1 | 19,6 |
Other operating costs | 0 | 0 | 0,2 | 360,8 |
Equity capital | 2,5 | 3,4 | 4,4 | 29,7 |
Operating profit (EBIT) | 0,5 | 1 | 1,1 | 7,2 |
Assets | 3,3 | 4,5 | 5,7 | 26,1 |
Net profit (loss) | 0,5 | 0,9 | 1 | 7,8 |
Cash | 2,2 | 2,3 | 3,8 | 69,1 |
Net income from sale | 6,3 | 8,7 | 10,8 | 23,9 |
Liabilities and provisions for liabilities | 0,8 | 1,2 | 1,3 | 15,7 |
Working assets | 3,2 | 4,5 | 5,7 | 27,1 |
Other income costs | 0 | 0 | 0,2 | 603,3 |
Depreciation | 0,2 | 0,2 | 0 | -80,6 |
% | % | % | p.p. | |
Profitability of capital | 22 | 27,6 | 22,9 | -4,7 |
Equity capital to total assets | 75,1 | 74,6 | 76,7 | 2,1 |
Gross profit margin | 8,3 | 12,7 | 11,3 | -1,4 |
EBITDA Margin | 11,5 | 14,2 | 10,6 | -3,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 43 | 40 | 39 | -1 |
Current financial liquidity indicator | 4.323266983032227 | 4.692349910736084 | 4.987430572509766 | 0,3 |
Net dept to EBITDA | -3.045839786529541 | -1.829210877418518 | -3.362075090408325 | -1,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane